These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 18971584

  • 1. Monthly ambient sunlight, infections and relapse rates in multiple sclerosis.
    Tremlett H, van der Mei IA, Pittas F, Blizzard L, Paley G, Mesaros D, Woodbaker R, Nunez M, Dwyer T, Taylor BV, Ponsonby AL.
    Neuroepidemiology; 2008; 31(4):271-9. PubMed ID: 18971584
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J, Hupperts R, Barkhof F, Grimaldi LM, Holmoy T, Killestein J, Rieckmann P, Schluep M, Vieth R, Hostalek U, Ghazi-Visser L, Beelke M, SOLAR study group.
    J Neurol Sci; 2011 Dec 15; 311(1-2):44-9. PubMed ID: 21620416
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study.
    Leone MA, Bonissoni S, Collimedaglia L, Tesser F, Calzoni S, Stecco A, Naldi P, Monaco F.
    Mult Scler; 2008 May 15; 14(4):485-93. PubMed ID: 18208889
    [Abstract] [Full Text] [Related]

  • 8. Clinical parameters to predict response to interferon in relapsing multiple sclerosis.
    Fromont A, Debouverie M, Le Teuff G, Quantin C, Binquet C, Moreau T.
    Neuroepidemiology; 2008 May 15; 31(3):150-6. PubMed ID: 18716412
    [Abstract] [Full Text] [Related]

  • 9. The relapse rate of multiple sclerosis changes during pregnancy: a cohort study.
    Salemi G, Callari G, Gammino M, Battaglieri F, Cammarata E, Cuccia G, D'Amelio M, Lupo I, Ragonese P, Savettieri G.
    Acta Neurol Scand; 2004 Jul 15; 110(1):23-6. PubMed ID: 15180803
    [Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G, Napoletano R, Esposito A.
    Eur Neurol; 2008 Jul 15; 59(1-2):44-8. PubMed ID: 17917457
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP, Rovaris M, Comi G, Filippi M.
    Neurology; 2009 Nov 10; 73(19):1538-42. PubMed ID: 19794123
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.
    Vercellino M, Romagnolo A, Mattioda A, Masera S, Piacentino C, Merola A, Chiò A, Mutani R, Cavalla P.
    Acta Neurol Scand; 2009 Feb 10; 119(2):126-30. PubMed ID: 18684216
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.